NF-κB, an inhibitor of microflora-induced colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 40, Issue SUPPL. 1, 2005, Pages

  Horwitz, Bruce ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTEIN P52; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB;

COLITIS; CONFERENCE PAPER; DISEASE EXACERBATION; GENE EXPRESSION REGULATION; HELICOBACTER HEPATICUS; HUMAN; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCID MOUSE;

ANIMALS; CHILD; COLITIS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTESTINAL MUCOSA; MICE; NF-KAPPA B; PROTEIN SUBUNITS;

HELICOBACTER HEPATICUS;

EID: 16444377964     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200504001-00012     Document Type: Conference Paper

References (5)

1. Erdman SE, Poutahidis T, Tomczak M, et al. CD4+CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Path 2003;162:691-702.
2. Maloy KJ, Salaun L, Cahill R, et al. CD4+CD25+ T regulatory cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-9.
3. Tomczak MF, Erdman SE, Poutahidis T, et al. 2003. NF-kappaB is required within the Innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J Immunol 2003;171: 1484-92.
4. Ogura Y, Bonen DK, Inohara K, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
5. Erdman S, Fox JG, Dangler CA, et al. Typhlocolitis in NF-kappa B-deficient mice. J Immunol 2001;166:1443-7.